Evidence map›Paper›PMID 24947513›Full record

ArticleThe Journal of biological chemistry2014

Mutagenesis studies of the H5 influenza hemagglutinin stem loop region.

Aleksandar Antanasijevic, Arnab Basu, Terry L Bowlin, Rama K Mishra, Lijun Rong, Michael Caffrey

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. VLP-Based Model for Study of Airborne Viral Pathogens.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Probing the metastable state of influenza hemagglutinin.The Journal of biological chemistry · 2017
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Aleksandar AntanasijevicFrom the Department of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607.
Arnab BasuMicrobiotix Inc., Worcester, Massachusetts 01605.
Terry L BowlinMicrobiotix Inc., Worcester, Massachusetts 01605.
Rama K Mishrathe Center for Molecular Innovation and Drug Discovery, Northwestern University, Evanston, Illinois 60208, and.
Lijun Rongthe Department of Microbiology and Immunology, University of Illinois, Chicago, Illinois 60612.
Michael CaffreyFrom the Department of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607, caffrey@uic.edu.
University of Illinois Chicago · USMicrobiotix (United States) · US

Funding

Identification of Novel Broad Spectrum Influenza Virus InhibitorsR44AI072861 · NIAID · MICROBIOTIX, INC · PI BASU, ARNAB · 2012 to 2014
$2.9M
Identification of Novel Broad Spectrum Influenza Virus InhibitorsR43AI072861 · NIAID · MICROBIOTIX, INC · PI BASU, ARNAB · 2008 to 2009
$500k
NMR-based discovery of influenza hemagglutinin probesR21AI101676 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CAFFREY, MICHAEL S. · 2012 to 2013
$427k
NIAID NIH HHS 1R21AI101676NIAID NIH HHS 5R44AI072861NIAID NIH HHS R21 AI101676NIAID NIH HHS R43 AI072861NIAID NIH HHS R44 AI072861
6 · The paper itself

Abstract

Influenza outbreaks, particularly the pandemic 1918 H1 and avian H5 strains, are of high concern to public health. The hemagglutinin envelope protein of influenza plays a critical role in viral entry and thus is an attractive target for inhibition of virus entry. The highly conserved stem loop region of hemagglutinin has been shown to undergo critically important conformational changes during the entry process and, moreover, to be a site for inhibition of virus entry by antibodies, small proteins, and small drug-like molecules. In this work we probe the structure-function properties of the H5 hemagglutinin stem loop region by site-directed mutagenesis. We find that most mutations do not disrupt expression, proteolytic processing, incorporation into virus, or receptor binding; however, many of the mutations disrupt the entry process. We further assess the effects of mutations on inhibition of entry by a neutralizing monoclonal antibody (C179) and find examples of increased and decreased sensitivity to the antibody, consistent with the antibody binding site observed by x-ray crystallography. In addition, we tested the sensitivity of the mutants to MBX2329, a small molecule inhibitor of influenza entry. Interestingly, the mutants exhibit increased and decreased sensitivities to MBX2329, which gives further insight into the binding site of the compound on HA and potential mechanisms of escape. Finally, we have modeled the binding site of MBX2329 using molecular dynamics and find that the resulting structure is in good agreement with the mutagenesis results. Together these studies underscore the importance of the stem loop region to HA function and suggest potential sites for therapeutic intervention of influenza entry.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralCrystallography, X-RayHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H5N1 SubtypeModels, MolecularMolecular Dynamics SimulationMolecular Sequence DataMutagenesis, Site-DirectedVirus InternalizationAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, Viralhemagglutinin, avian influenza A virusHemagglutinin Glycoproteins, Influenza VirusAntiviral AgentGlycoprotein StructureInfluenzaSite-directed mutagenesisVirus Entry

Identifiers

PMID24947513
PMCPMC4139235
OpenAlexW2024657330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.